Literature DB >> 23164759

Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation.

Andrea Deutschmann1, Axel Schlagenhauf, Bettina Leschnik, Karl Martin Hoffmann, Almuthe Hauer, Wolfgang Muntean.   

Abstract

OBJECTIVES: Patients with inflammatory bowel disease (IBD) have a higher risk for venous thromboembolism compared with non-IBD subjects. The pathogenic mechanisms of the thrombotic events are not fully understood. We investigated levels of circulating microparticles and their influence on thrombin generation in pediatric patients with IBD during active and quiescent disease compared with healthy controls.
METHODS: Plasma samples were collected from 33 pediatric patients with Crohn disease (CD), 20 pediatric patients with ulcerative colitis (UC), and 60 healthy controls. Microparticles' procoagulant activity was measured by enzyme-linked immunosorbent assay, and the dependency of thrombin generation on microparticles-derived tissue factor was determined by means of calibrated automated thrombography.
RESULTS: The procoagulant function of microparticles was significantly increased in patients with active and inactive CD, and active UC compared with controls. Endogenous thrombin potential was significantly higher in patients with CD and UC compared with controls. A minor influence of microparticles on thrombin generation was only observed for patients with active UC.
CONCLUSIONS: Our study shows increased procoagulant function of microparticles in pediatric patients with active and quiescent CD and active UC compared with controls, but demonstrates that they are not a major cause for the higher thrombin generation in pediatric patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23164759     DOI: 10.1097/MPG.0b013e31827daf72

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

Review 1.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

2.  Targeted inhibition of thrombin attenuates murine neonatal necrotizing enterocolitis.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Darla R Shores; Sunil K Jain; Jennifer Fundora; Allen D Everett; Ling He; Hua Pan; Samuel A Wickline; Akhil Maheshwari
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

Review 3.  Thromboembolic complications in inflammatory bowel disease.

Authors:  Darina Kohoutova; Paula Moravkova; Peter Kruzliak; Jan Bures
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

4.  Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.

Authors:  Daniela Leonetti; Jean-Marie Reimund; Angela Tesse; Stéphanie Viennot; Maria Carmen Martinez; Anne-Laure Bretagne; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

5.  Coagulation factor 9-deficient mice are protected against dextran sulfate sodium-induced colitis.

Authors:  Avinash Khandagale; Jens M Kittner; Amrit Mann; Stefanie Ascher; Bettina Kollar; Christoph Reinhardt
Journal:  Biol Open       Date:  2018-07-25       Impact factor: 2.422

Review 6.  Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses.

Authors:  Catalina Burbano; Mauricio Rojas; Gloria Vásquez; Diana Castaño
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

7.  Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use.

Authors:  Saeid Mezail Mawazi; Sinan Mohammed Abdullah Al-Mahmood; Bappaditya Chatterjee; Hazrina Ab Hadi; Abd Almonem Doolaanea
Journal:  Pharmaceutics       Date:  2019-09-20       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.